55 North Private Wealth’s AbbVie ABBV Stock Holding History

55 North Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$786K	Buy	3,124 +372	+14%	+$80K	0.15%	70
2026 Q1	$598K	Buy	2,752 +100	+4%	+$22.2K	0.15%	66
2025 Q4	$606K	Buy	+2,652	New	+$604K	0.16%	65

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

55 North Private Wealth's ABBV Position: Q2 2026 in Review

55 North Private Wealth increased its AbbVie (ABBV) stake by 14% in Q2 2026, buying an estimated $80K and bringing the position to 3,124 shares worth $786K. The position accounts for 0.15% of the portfolio, ranked #70.

55 North Private Wealth first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

55 North Private Wealth held 3,124 shares of AbbVie worth $786K as of Q2 2026.
55 North Private Wealth bought 372 AbbVie shares in Q2 2026, an estimated $80K.
AbbVie made up 0.15% of 55 North Private Wealth's portfolio in Q2 2026, its #70 holding.
55 North Private Wealth first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 55 North Private Wealth's 13F filing for Q2 2026, filed 7 Jul 2026.